Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies
- DOI
- 10.1016/j.esmoop.2026.107698
- Published
- 2026-06
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.107698,
title = {Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies},
author = {S.B. Maron and R.-H. Xu and Z.A. Wainberg and S.Y. Rha and Y. Zhang and F. Pietrantonio and S.C.S. Oliveira and Y. Li and M.-H. Chen and K. Korphaisarn and E. Elimova and C.A. Calderon and F.V. Herpe and W.P. Yong and T.M. Dos Santos and M. Tan and K. Isse and R.E. Yanes and K. Shitara},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.107698},
url = {https://doi.org/10.1016/j.esmoop.2026.107698}
}RIS
TY - JOUR TI - Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies AU - S.B. Maron AU - R.-H. Xu AU - Z.A. Wainberg AU - S.Y. Rha AU - Y. Zhang AU - F. Pietrantonio AU - S.C.S. Oliveira AU - Y. Li AU - M.-H. Chen AU - K. Korphaisarn AU - E. Elimova AU - C.A. Calderon AU - F.V. Herpe AU - W.P. Yong AU - T.M. Dos Santos AU - M. Tan AU - K. Isse AU - R.E. Yanes AU - K. Shitara PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.107698 UR - https://doi.org/10.1016/j.esmoop.2026.107698 ER -
APA
Maron, S., Xu, R., Wainberg, Z., Rha, S., Zhang, Y., Pietrantonio, F., Oliveira, S., Li, Y., Chen, M., Korphaisarn, K., Elimova, E., Calderon, C., Herpe, F., Yong, W., Santos, T. D., Tan, M., Isse, K., Yanes, R., & Shitara, K. (2026). Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.107698
Source records
- crossref · retrieved 2026-09-26T06:55:10.437Z